Aduhelm and the Microcosm of What is Wrong with our Drug Approval and Pricing Process - a podcast by Marc S. Ryan

from 2022-04-28T07:00

:: ::

In this edition of The Healthcare Revolution podcast, MHK President Marc S. Ryan examines the recent controversy over the approval of Aduhelm and the backtracking the government did on coverage of the drug in Medicare. It is a microcosm about what is wrong with our drug approval and pricing process.

Further episodes of The Healthcare Revolution with MHK

Further podcasts by Marc S. Ryan

Website of Marc S. Ryan